Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-17

Clinical Trial Update: UnityPhilly Response App for Overdose Reversal

View source ↗

Summary

Drexel University-sponsored clinical trial evaluating the UnityPhilly Response App for opioid overdose reversal is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UnityPhilly Response App

Snippet

Sponsor: Drexel University | Conditions: Opioid Overdose | Status: NOT_YET_RECRUITING